Back to Clinical Trials Overview
Back To Cancer Clinical Trials
Phase I/Randomized Phase II Double Blind Study of Either Dasatinib or Placebo Combined with Bevacizumab in Recurrent Glioblastoma (Study 2)
Principal Investigator(s): Philip Friedlander
A Prospective, Multi-center Trial of NovoTTF-100A Together With Temozolomide Compared to Temozolomide Alone in Patients with Newly Diagnosed GBM
Principal Investigator(s): Isabelle M. Germano
Back To Cancer Clinical Trials
Your search for "Brain and Nervous System" returned 2 results:
Phase I/Randomized Phase II Double Blind Study of Either Dasatinib or Placebo Combined with Bevacizumab in Recurrent Glioblastoma (Study 2)
Principal Investigator(s): Philip Friedlander
A Prospective, Multi-center Trial of NovoTTF-100A Together With Temozolomide Compared to Temozolomide Alone in Patients with Newly Diagnosed GBM
Principal Investigator(s): Isabelle M. Germano
Contact Us
Office of Research Services (ORS)
Tel: 212-824-7294
Send e-mail
Related Resources
For Patients
- Find a Mount Sinai Doctor
- Find a Mount Sinai Department or Institute
- Research Match
- Clinicaltrials.gov
- National Cancer Clinical Trials
- Video - Participating in Research - You Can Be Part of the Answer
- The Center for Information & Study on Clinical Research Participation
- Patients Like Me
For Investigators
- Office of Research Services (ORS)
- How to Post Research Projects on the Website
- Conduits
- Research Information Technology
- Communicating with Research Subjects